Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Individualized Medical Nutrition Therapy on Glycemic Control, Inflammation, and Gut Barrier Regulation in Adults With Type 2 Diabetes Mellitus: a RCT

NCT07037212 is registered in ClinicalTrials.gov with Serap Balaban Barta as lead sponsor.

NCT NCT07037212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07037212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Individualized Medical Nutrition Therapy on Glycemic Control, Inflammation, and Gut Barrier Regulation in Adults With Type 2 Diabetes Mellitus: a RCT
Lead sponsor
Serap Balaban Barta
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2020
Completion date
October 10, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glycemic control, intestinal permeability, systemic inflammation, type 2 diabetes mellitus (t2dm)